State Street Corp Biofrontera Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$37.2 - $99.2 $305,040 - $813,440
8,200 Added 55.78%
22,900 $43,000
Q1 2022

May 16, 2022
BUY
$45.0 - $138.4 $661,500 - $2.03 Million
14,700 New
14,700 $49,000

About Biofrontera Inc.

BFRI Quotes by TradingView
  • Ticker BFRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 23,551,000
  • Market Cap $22.6M
  • Description
  • Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for phot...
More about BFRI
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email